Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Thalassemia × Mesna × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 11 Lymphoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia 10 Hodgkin Disease 7 Sarcoma 6 Hematologic Neoplasms 6 Neoplasms 5 Myelodysplastic Syndromes 5 Leukemia, Myeloid, Acute 5 Neuroblastoma 4 Multiple Myeloma 4 Lymphoma, Mantle-Cell 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Myeloproliferative Disorders 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Breast Neoplasms 3 Vomiting 2 Testicular Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Nausea 2 Thalassemia 1 Teratoma 1 Seminoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

fludarabine phosphate 2 Cyclophosphamide 2 fludarabine 1 Whole-Body Irradiation 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Busulfan 1 Alemtuzumab 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡